These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 26505644)
1. Analysis of the ToxCast Chemical-Assay Space Using the Comparative Toxicogenomics Database. Hu B; Gifford E; Wang H; Bailey W; Johnson T Chem Res Toxicol; 2015 Nov; 28(11):2210-23. PubMed ID: 26505644 [TBL] [Abstract][Full Text] [Related]
2. Analysis of Pfizer compounds in EPA's ToxCast chemicals-assay space. Shah F; Greene N Chem Res Toxicol; 2014 Jan; 27(1):86-98. PubMed ID: 24328225 [TBL] [Abstract][Full Text] [Related]
3. Using ToxCast to Explore Chemical Activities and Hazard Traits: A Case Study With Ortho-Phthalates. Pham N; Iyer S; Hackett E; Lock BH; Sandy M; Zeise L; Solomon G; Marty M Toxicol Sci; 2016 Jun; 151(2):286-301. PubMed ID: 26969370 [TBL] [Abstract][Full Text] [Related]
4. Comparative endpoint sensitivity of in vitro estrogen agonist assays. Dreier DA; Connors KA; Brooks BW Regul Toxicol Pharmacol; 2015 Jul; 72(2):185-93. PubMed ID: 25896097 [TBL] [Abstract][Full Text] [Related]
5. A Comparison of ToxCast Test Results with In Vivo and Other In Vitro Endpoints for Neuro, Endocrine, and Developmental Toxicities: A Case Study Using Endosulfan and Methidathion. Silva M; Pham N; Lewis C; Iyer S; Kwok E; Solomon G; Zeise L Birth Defects Res B Dev Reprod Toxicol; 2015 Apr; 104(2):71-89. PubMed ID: 26017137 [TBL] [Abstract][Full Text] [Related]
6. Contribution of new technologies to characterization and prediction of adverse effects. Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431 [TBL] [Abstract][Full Text] [Related]
7. A CTD-Pfizer collaboration: manual curation of 88,000 scientific articles text mined for drug-disease and drug-phenotype interactions. Davis AP; Wiegers TC; Roberts PM; King BL; Lay JM; Lennon-Hopkins K; Sciaky D; Johnson R; Keating H; Greene N; Hernandez R; McConnell KJ; Enayetallah AE; Mattingly CJ Database (Oxford); 2013; 2013():bat080. PubMed ID: 24288140 [TBL] [Abstract][Full Text] [Related]
8. Chemical-Induced Phenotypes at CTD Help Inform the Predisease State and Construct Adverse Outcome Pathways. Davis AP; Wiegers TC; Wiegers J; Johnson RJ; Sciaky D; Grondin CJ; Mattingly CJ Toxicol Sci; 2018 Sep; 165(1):145-156. PubMed ID: 29846728 [TBL] [Abstract][Full Text] [Related]
9. Ranking transitive chemical-disease inferences using local network topology in the comparative toxicogenomics database. King BL; Davis AP; Rosenstein MC; Wiegers TC; Mattingly CJ PLoS One; 2012; 7(11):e46524. PubMed ID: 23144783 [TBL] [Abstract][Full Text] [Related]
10. An integrative data mining approach to identifying adverse outcome pathway signatures. Oki NO; Edwards SW Toxicology; 2016 Mar; 350-352():49-61. PubMed ID: 27108252 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of food-relevant chemicals in the ToxCast high-throughput screening program. Karmaus AL; Filer DL; Martin MT; Houck KA Food Chem Toxicol; 2016 Jun; 92():188-96. PubMed ID: 27103583 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of in vivo and in vitro models of toxicity by comparison of toxicogenomics data with the literature. Taškova K; Fontaine JF; Mrowka R; Andrade-Navarro MA Methods; 2018 Jan; 132():57-65. PubMed ID: 28716510 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships. Liu Z; Kelly R; Fang H; Ding D; Tong W Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106 [TBL] [Abstract][Full Text] [Related]
15. Generating Gene Ontology-Disease Inferences to Explore Mechanisms of Human Disease at the Comparative Toxicogenomics Database. Davis AP; Wiegers TC; King BL; Wiegers J; Grondin CJ; Sciaky D; Johnson RJ; Mattingly CJ PLoS One; 2016; 11(5):e0155530. PubMed ID: 27171405 [TBL] [Abstract][Full Text] [Related]
16. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay. Beames T; Moreau M; Roberts LA; Mansouri K; Haider S; Smeltz M; Nicolas CI; Doheny D; Phillips MB; Yoon M; Becker RA; McMullen PD; Andersen ME; Clewell RA; Hartman JK Toxicol Appl Pharmacol; 2020 Jan; 387():114774. PubMed ID: 31783037 [TBL] [Abstract][Full Text] [Related]
17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
19. Acute Toxicity Prediction in Multiple Species by Leveraging Mechanistic ToxCast Mitochondrial Inhibition Data and Simulation of Oral Bioavailability. Bhhatarai B; Wilson DM; Bartels MJ; Chaudhuri S; Price PS; Carney EW Toxicol Sci; 2015 Oct; 147(2):386-96. PubMed ID: 26139166 [TBL] [Abstract][Full Text] [Related]
20. LTMap: a web server for assessing the potential liver toxicity by genome-wide transcriptional expression data. Xing L; Wu L; Liu Y; Ai N; Lu X; Fan X J Appl Toxicol; 2014 Jul; 34(7):805-9. PubMed ID: 24022982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]